Soleus Capital Management, L.P.
Q3 2026 13F filing
Updated 6 days ago97 disclosed positions worth $2.8B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | K KRYSTAL BIOTECH INC | $379M | 1.14M | 13.47% | — |
| 2 | P INSULET CORP | $225.3M | 1.73M | 8.01% | — |
| 3 | N NOVOCURE LTD | $150.3M | 9.43M | 5.34% | — |
| 4 | T TG THERAPEUTICS INC | $142.6M | 2.56M | 5.07% | — |
| 5 | U UNITED THERAPEUTICS CORP DEL | $140.3M | 259.0K | 4.99% | — |
| 6 | C CELCUITY INC | $133.8M | 1.68M | 4.76% | — |
| 7 | R RIGEL PHARMACEUTICALS INC | $88.8M | 1.84M | 3.16% | — |
| 8 | I INSPIRE MED SYS INC | $83.7M | 1.21M | 2.98% | — |
| 9 | E ERASCA INC | $74.9M | 5.11M | 2.66% | — |
| 10 | B BETA BIONICS INC | $71.1M | 3.74M | 2.53% | — |
| 11 | A ANI PHARMACEUTICALS INC | $70.9M | 975.5K | 2.52% | — |
| 12 | V VERICEL CORP | $62.4M | 1.55M | 2.22% | — |
| 13 | G GERON CORP | $57.5M | 46.77M | 2.04% | — |
| 14 | P PARABILIS MEDICINES INC | $54.4M | 1.68M | 1.93% | — |
| 15 | A ARGENX SE | $47.3M | 49.4K | 1.68% | — |
| 16 | A AXOGEN INC | $45.3M | 1.08M | 1.61% | — |
| 17 | N NEUROPACE INC | $44.3M | 3.22M | 1.57% | — |
| 18 | E EVOLUS INC | $40.7M | 5.09M | 1.45% | — |
| 19 | Z ZAI LAB LTD | $40.6M | 1.54M | 1.44% | — |
| 20 | P PROGYNY INC | $39.9M | 1.58M | 1.42% | — |
| 21 | T TREVI THERAPEUTICS INC | $39.1M | 2.73M | 1.39% | — |
| 22 | N NUVECTIS PHARMA INC | $36.1M | 1.71M | 1.28% | — |
| 23 | F EDAP TMS S A | $32.7M | 7.31M | 1.16% | — |
| 24 | A AVALYN PHARMACEUTICALS INC | $29M | 1.02M | 1.03% | — |
| 25 | K KODIAK SCIENCES INC | $27.2M | 287.0K | 0.97% | — |
| 26 | S SILENCE THERAPEUTICS PLC | $26.1M | 2.39M | 0.93% | — |
| 27 | I INHIBIKASE THERAPEUTICS INC | $23.1M | 11.22M | 0.82% | — |
| 28 | R ARCUS BIOSCIENCES INC | $22.3M | 862.0K | 0.79% | — |
| 29 | L LEGEND BIOTECH CORP | $21.6M | 1.09M | 0.77% | — |
| 30 | N NURIX THERAPEUTICS INC | $21.2M | 892.2K | 0.75% | — |
| 31 | I INHIBRX BIOSCIENCES INC | $21M | 210.0K | 0.75% | — |
| 32 | A ADLAI NORTYE GROUP LTD | $20.4M | 1.27M | 0.72% | — |
| 33 | ? N/A PALISADE BIO INC | $20.2M | 15.00M | 0.72% | — |
| 34 | A ALKERMES PLC | $20.2M | 497.7K | 0.72% | — |
| 35 | T TANGO THERAPEUTICS INC | $20M | 802.3K | 0.71% | — |
| 36 | B BIODESIX INC | $19.9M | 667.8K | 0.71% | — |
| 37 | P PHARVARIS N V | $19.2M | 604.0K | 0.68% | — |
| 38 | I INSMED INC | $16.8M | 147.0K | 0.60% | — |
| 39 | P PRAXIS PRECISION MEDICINES I | $16.5M | 56.5K | 0.59% | — |
| 40 | J JADE BIOSCIENCES INC | $16.5M | 1.17M | 0.58% | — |
| 41 | K KINIKSA PHARMACEUTICALS INTL | $16.3M | 219.0K | 0.58% | — |
| 42 | C CONMED CORP | $16.1M | 347.3K | 0.57% | — |
| 43 | E ETON PHARMACEUTICALS INC | $15.9M | 308.1K | 0.56% | — |
| 44 | K ORTHOPEDIATRICS CORP | $15.8M | 710.2K | 0.56% | — |
| 45 | O ORGANOGENESIS HLDGS INC | $15.5M | 11.30M | 0.55% | — |
| 46 | G GRAIL INC | $15.2M | 108.5K | 0.54% | — |
| 47 | M MBX BIOSCIENCES INC | $15.2M | 258.9K | 0.54% | — |
| 48 | E EDGEWISE THERAPEUTICS INC | $13.4M | 330.0K | 0.48% | — |
| 49 | A AMNEAL PHARMACEUTICALS INC | $13.3M | 658.0K | 0.47% | — |
| 50 | P PRELUDE THERAPEUTICS INC | $13.2M | 3.38M | 0.47% | — |